Invasive Heart Procedures Decrease at 75
        
        From the corporate.dukehealth.org archives. Content may be out of date.
    
ATLANTA, GA -- Duke University Medical Center cardiologists
    have found that the use of invasive procedures used to clear
    clogged heart vessels declines as the age of patients
    increases, with the decrease especially noticeable after the
    age of 75.
Although the reasons for this decline are unclear, the
    researchers believe that -- based on their analysis of large
    clinical trials and their survey of patient preferences -- the
    key might lie in the complex interaction between patients and
    their physicians when treatment options are being
    discussed.
In two poster presentations at the 51st annual scientific
    sessions of the American College of Cardiology, Duke
    cardiologist Karen Alexander, M.D., sheds new light on this
    phenomenon affecting an ever-growing population.
"As the population ages, we are seeing more and more elderly
    people with symptoms of heart disease, and these patients are
    safely receiving such invasive procedures as bypass surgery and
    angioplasty," Alexander said. "Interestingly, the usage of
    these procedures declines markedly at the age of 75. We don't
    know why, or whether it is necessarily right or wrong, but the
    trend is there, clear and strong."
Alexander hopes that the decline is not due to ageism, in
    which physicians might not want to consider invasive
    procedures, basing their recommendations solely on a patient's
    age. One problem physicians face when explaining procedures or
    new therapies to the elderly is insufficient clinical data,
    since only 2 percent of all clinical trials enroll patients
    over the age of 75.
"There is very little data out there for physicians to use
    when discussing possible procedures with their elderly
    patients," Alexander said.
"Ideally physicians should be able to discuss the potential
    risks and benefits of any procedure regardless of age, and the
    elderly patients should be able to fully understand their
    options."
Alexander first pooled and analyzed the data gathered from
    two related international trials -- SYMPHONY and Second
    SYMPHONY (Sibrafabin vs. aspirin to yield maximum protection
    from ischemic heart events post-acute coronary syndromes).
    These trials compared the effectiveness of aspirin to
    a new class of drugs that dissolves blood clots.
Using this database, which included more than 15,000
    patients in 35 countries, she examined the rates of invasive
    procedures among those who were older than 75 and those who
    were younger. Of these patients, 11.3 percent were 75 or
    older.
"Compared with younger patients, the elderly tended to be
    female, with high blood pressures, diabetes and they tended to
    have had a prior heart attack," Alexander said.
"They also had fewer cardiac catheterizations (53 percent
    vs. 63 percent) and angioplasties (28 percent vs. 37 percent),
    but had slightly more bypass surgeries (8 percent vs. 7
    percent).
"However, when we controlled for all these factors, as well
    as their risk factors, we still saw this age-related decline,
    which became more pronounced after age 75," Alexander
    continued.
One possible explanation, the researchers believe, was that
    as patients age, they might become less likely to want to risk
    an invasive procedure. To test this hypothesis, Alexander
    conducted a patient preference survey of 678 patients admitted
    to Duke University Hospital for chest pain prior to a
    referral for cardiac catheterization. Of these patients, 274
    (40.4 percent) were at least 75 years old.
The surveys measured patients' willingness to undergo an
    invasive procedure, as well as their knowledge of the
    procedures and their
    risk-tolerance for the potential of dying during bypass
    surgery. The researchers also collected medical data.
"We found that while patient willingness to consider
    invasive procedures and accept risks declines with advancing
    age, the vast majority of elderly patients will still consider
    these treatments when recommended," Alexander said. "So, it
    appears that patient preferences are unlikely to explain
    age-related declines in cardiac procedure use."
Specifically, 82.6 percent of the elderly were willing to
    consider cardiac catheterization (compared to 91.4 percent for
    the younger patients). For angioplasty, 70 percent of the
    elderly were willing to consider the procedures, compared to
    86.9 percent for the younger patients. For bypass
    surgery, 55.2 percent of the elderly were willing to consider
    the operation, compared to 72.5 percent for the younger
    patients.
"There is no way around that fact that, in general, patient
    outcomes get worse as patients age, however, the main question
    is will they do worse without the treatment," Alexander said.
    "The key is what happens when the patient and physicians are
    discussing the patients' medical situation and the available
    options for treating it.
"We want to make sure that patients who could potentially
    benefit from these procedures are not being subtly or overtly
    dissuaded from having these procedures based solely on age,"
    she continued.
Alexander is currently designing a study that will determine
    which specific elderly patients have the most to gain from
    these procedures. She hopes to be able to find those patients
    who may be physically "younger" than their chronological
    age.
Both of the SYMPHONY trials, from which the elderly data was
    gleaned, were funded by F. Hoffman-La Roche, Basel,
    Switzerland. Alexander's patient preference survey was
    supported by a grant from the Doris Duke Foundation.
Joining Alexander in the patient preference survey were Duke
    colleagues Tina Harding, Laura Coombs, Ph.D., Katherine Taylor
    and Eric Peterson, M.D.